Literature DB >> 26361169

Synopsis of the PI-RADS v2 Guidelines for Multiparametric Prostate Magnetic Resonance Imaging and Recommendations for Use.

Jelle O Barentsz1, Jeffrey C Weinreb2, Sadhna Verma3, Harriet C Thoeny4, Clare M Tempany5, Faina Shtern6, Anwar R Padhani7, Daniel Margolis8, Katarzyna J Macura9, Masoom A Haider10, Francois Cornud11, Peter L Choyke12.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26361169      PMCID： PMC6364687          DOI： 10.1016/j.eururo.2015.08.038

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  22 in total

1.  A critical analysis of the tumor volume threshold for clinically insignificant prostate cancer using a data set of a randomized screening trial.

Authors:  Tineke Wolters; Monique J Roobol; Pim J van Leeuwen; Roderick C N van den Bergh; Robert F Hoedemaeker; Geert J L H van Leenders; Fritz H Schröder; Theodorus H van der Kwast
Journal:  J Urol       Date:  2010-11-12       Impact factor: 7.450

2.  Consensus criteria for the use of magnetic resonance imaging in the diagnosis and staging of prostate cancer: not ready for routine use.

Authors:  Axel Heidenreich
Journal:  Eur Urol       Date:  2011-01-18       Impact factor: 20.096

3.  Multiparametric MR imaging for detection of clinically significant prostate cancer: a validation cohort study with transperineal template prostate mapping as the reference standard.

Authors:  Nimalan Arumainayagam; Hashim U Ahmed; Caroline M Moore; Alex Freeman; Clare Allen; S Aslam Sohaib; Alex Kirkham; Jan van der Meulen; Mark Emberton
Journal:  Radiology       Date:  2013-04-05       Impact factor: 11.105

4.  Validation of the European Society of Urogenital Radiology scoring system for prostate cancer diagnosis on multiparametric magnetic resonance imaging in a cohort of repeat biopsy patients.

Authors:  Daniel Portalez; Pierre Mozer; François Cornud; Raphaëlle Renard-Penna; Vincent Misrai; Matthieu Thoulouzan; Bernard Malavaud
Journal:  Eur Urol       Date:  2012-06-27       Impact factor: 20.096

5.  Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations.

Authors:  Anwar R Padhani; Guoying Liu; Dow Mu Koh; Thomas L Chenevert; Harriet C Thoeny; Taro Takahara; Andrew Dzik-Jurasz; Brian D Ross; Marc Van Cauteren; David Collins; Dima A Hammoud; Gordon J S Rustin; Bachir Taouli; Peter L Choyke
Journal:  Neoplasia       Date:  2009-02       Impact factor: 5.715

6.  Prebiopsy magnetic resonance imaging and prostate cancer detection: comparison of random and targeted biopsies.

Authors:  Nicolas Barry Delongchamps; Michaël Peyromaure; Alexandre Schull; Frédéric Beuvon; Naïm Bouazza; Thierry Flam; Marc Zerbib; Naira Muradyan; Paul Legman; François Cornud
Journal:  J Urol       Date:  2012-10-08       Impact factor: 7.450

7.  Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting.

Authors:  Louise Dickinson; Hashim U Ahmed; Clare Allen; Jelle O Barentsz; Brendan Carey; Jurgen J Futterer; Stijn W Heijmink; Peter J Hoskin; Alex Kirkham; Anwar R Padhani; Raj Persad; Philippe Puech; Shonit Punwani; Aslam S Sohaib; Bertrand Tombal; Arnauld Villers; Jan van der Meulen; Mark Emberton
Journal:  Eur Urol       Date:  2010-12-21       Impact factor: 20.096

8.  Performance of multiparametric MRI in men at risk of prostate cancer before the first biopsy: a paired validating cohort study using template prostate mapping biopsies as the reference standard.

Authors:  M Abd-Alazeez; A Kirkham; H U Ahmed; M Arya; E Anastasiadis; S C Charman; A Freeman; M Emberton
Journal:  Prostate Cancer Prostatic Dis       Date:  2013-10-15       Impact factor: 5.554

9.  ESUR prostate MR guidelines 2012.

Authors:  Jelle O Barentsz; Jonathan Richenberg; Richard Clements; Peter Choyke; Sadhna Verma; Geert Villeirs; Olivier Rouviere; Vibeke Logager; Jurgen J Fütterer
Journal:  Eur Radiol       Date:  2012-02-10       Impact factor: 5.315

10.  The accuracy of multiparametric MRI in men with negative biopsy and elevated PSA level--can it rule out clinically significant prostate cancer?

Authors:  Mohamed Abd-Alazeez; Hashim U Ahmed; Manit Arya; Susan C Charman; Eleni Anastasiadis; Alex Freeman; Mark Emberton; Alex Kirkham
Journal:  Urol Oncol       Date:  2013-09-18       Impact factor: 3.498
View more
  140 in total

1.  Accuracy and agreement of PIRADSv2 for prostate cancer mpMRI: A multireader study.

Authors:  Matthew D Greer; Anna M Brown; Joanna H Shih; Ronald M Summers; Jamie Marko; Yan Mee Law; Sandeep Sankineni; Arvin K George; Maria J Merino; Peter A Pinto; Peter L Choyke; Baris Turkbey
Journal:  J Magn Reson Imaging       Date:  2016-07-08       Impact factor: 4.813

2.  Three-dimensional simultaneous brain T1 , T2 , and ADC mapping with MR Multitasking.

Authors:  Sen Ma; Christopher T Nguyen; Fei Han; Nan Wang; Zixin Deng; Nader Binesh; Franklin G Moser; Anthony G Christodoulou; Debiao Li
Journal:  Magn Reson Med       Date:  2019-11-25       Impact factor: 4.668

3.  Clinico-radiological characteristic-based machine learning in reducing unnecessary prostate biopsies of PI-RADS 3 lesions with dual validation.

Authors:  Yansheng Kan; Qing Zhang; Jiange Hao; Wei Wang; Junlong Zhuang; Jie Gao; Haifeng Huang; Jing Liang; Giancarlo Marra; Giorgio Calleris; Marco Oderda; Xiaozhi Zhao; Paolo Gontero; Hongqian Guo
Journal:  Eur Radiol       Date:  2020-06-10       Impact factor: 5.315

4.  Clinical use of magnetic resonance imaging across the prostate brachytherapy workflow.

Authors:  P Blanchard; C Ménard; S J Frank
Journal:  Brachytherapy       Date:  2017-01-30       Impact factor: 2.362

Review 5.  Prostate MRI and transperineal TRUS/MRI fusion biopsy for prostate cancer detection: clinical practice updates.

Authors:  Eugenio Martorana; Giacomo Maria Pirola; Maria Cristina Aisa; Pietro Scialpi; Aldo Di Blasi; Giovanni Saredi; Alfredo D'Andrea; Stefano Signore; Riccardo Grisanti; Michele Scialpi
Journal:  Turk J Urol       Date:  2019-07-01

6.  Novel Structured Reporting Systems for Theranostic Radiotracers.

Authors:  Rudolf A Werner; Ralph A Bundschuh; Lena Bundschuh; Stefano Fanti; Mehrbod S Javadi; Takahiro Higuchi; Alexander Weich; Kenneth J Pienta; Andreas K Buck; Martin G Pomper; Michael A Gorin; Ken Herrmann; Constantin Lapa; Steven P Rowe
Journal:  J Nucl Med       Date:  2019-02-22       Impact factor: 10.057

7.  Evaluating the size criterion for PI-RADSv2 category 5 upgrade: is 15 mm the best threshold?

Authors:  Julie Y An; Stephanie A Harmon; Sherif Mehralivand; Marcin Czarniecki; Clayton P Smith; Julie A Peretti; Bradford J Wood; Peter A Pinto; Peter L Choyke; Joanna H Shih; Baris Turkbey
Journal:  Abdom Radiol (NY)       Date:  2018-12

8.  Multiparametric MRI Apparent Diffusion Coefficient (ADC) Accuracy in Diagnosing Clinically Significant Prostate Cancer.

Authors:  Pietro Pepe; Davide D'Urso; Antonio Garufi; Giandomenico Priolo; Michele Pennisi; Giorgio Russo; Maria Gabriella Sabini; Lucia Maria Valastro; Antonio Galia; Filippo Fraggetta
Journal:  In Vivo       Date:  2017 May-Jun       Impact factor: 2.155

Review 9.  Prostate imaging reporting and data system version 2 (PI-RADS v2): a pictorial review.

Authors:  Elmira Hassanzadeh; Daniel I Glazer; Ruth M Dunne; Fiona M Fennessy; Mukesh G Harisinghani; Clare M Tempany
Journal:  Abdom Radiol (NY)       Date:  2017-01

10.  Prostate Imaging-Reporting and Data System Steering Committee: PI-RADS v2 Status Update and Future Directions.

Authors:  Anwar R Padhani; Jeffrey Weinreb; Andrew B Rosenkrantz; Geert Villeirs; Baris Turkbey; Jelle Barentsz
Journal:  Eur Urol       Date:  2018-06-13       Impact factor: 20.096
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.